Member

Sirpa PIETIKÄINEN

EPP · Finland

Group: EPP PPE
Country: Finland
Roll-call participation: 87.9 %ⓘ of 572 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line: 90.9 %ⓘ of 503 votes where the group had a line · EPP median 95.6 %

More facts (5)

National party: KOK Kansallinen Kokoomus
In office: Since 1 Dec 2024
Against clear line: 29 of 477 votesⓘ
Committees: ECON, ENVI (substitute), FEMM, SANT (substitute)
Member id: 40599

National party: KOK Kansallinen Kokoomus
In office: Since 1 Dec 2024
Against clear line: 29 of 477 votesⓘ
Committees: ECON, ENVI (substitute), FEMM, SANT (substitute)
Member id: 40599

Cite this page

EP profile

Link to this page

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Period Whole term 2024 (from July)2025 2026

Custom dates

Votes Final votes620 All roll calls5 928

Roll-call participation ⓘ

87.9 %

503 of 572 final votes while in office

EPP median: 90.6 % (−2.6 pts)

Chamber median: 90.6 %

With majority line ⓘ

90.9 %

457 of 503 votes where their group had a line

EPP median: 95.6 % (−4.7 pts)

Against clear line ⓘ

6.1 %

29 of 477 votes where their group had a clear line

21 opposite (for ↔ against), 8 abstained against the line

Abstention ⓘ

1.6 %

8 of 503 votes cast

Participation 87.9 % — EPP median 90.6 %, 192 members.ⓘ

Data as a table

Participation among the 192 members of the EPP with enough votes.
Figure	Participation
Sirpa PIETIKÄINEN	87.9 %
EPP median	90.6 %
Lowest in the group	18.4 %
Highest in the group	99.8 %
Members	192

With majority line 90.9 % — EPP median 95.6 %, 192 members.ⓘ

Data as a table

With majority line among the 192 members of the EPP with enough votes.
Figure	With majority line
Sirpa PIETIKÄINEN	90.9 %
EPP median	95.6 %
Lowest in the group	67.8 %
Highest in the group	99.0 %
Members	192

Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of EPP; no ranks.
“No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 572

Export

Every final roll-call vote of the term with the member’s position, newest first.

Show Final votes All roll calls

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
Date	Decision	Result	Position	Majority line
6 May 2025	Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2024/003 BE/Van Hool – Belgium	Passed 598 for, 48 against, 5 abstained	Position: For	Majority line: For
6 May 2025	Protection of the European Union’s financial interests – combating fraud – annual report 2023	Adopted 473 for, 59 against, 114 abstained	Position: For	Majority line: For
6 May 2025	Control of the financial activities of the European Investment Bank – annual report 2023	Adopted 340 for, 162 against, 150 abstained	Position: For	Majority line: For
3 Apr 2025	Establishing an EU talent pool	Negotiating mandate approved 327 for, 229 against, 50 abstained	Position: For	Majority line: For
3 Apr 2025	Granting equivalence with EU requirements to Moldova and Ukraine as regards field inspections and production of seed	Negotiating mandate approved 411 for, 191 against, 13 abstained	Position: For	Majority line: For
3 Apr 2025	Amending Directives (EU) 2022/2464 and (EU) 2024/1760 as regards the dates from which Member States are to apply certain corporate sustainability reporting and due diligence requirements	Passed 531 for, 69 against, 17 abstained	Position: No vote recorded	Majority line: For
3 Apr 2025	Estimates of revenue and expenditure for the financial year 2026 – Section I – European Parliament	Adopted 432 for, 127 against, 54 abstained	Position: For	Majority line: For
3 Apr 2025	Immediate risk of further repression by Lukashenka’s regime in Belarus - threats from the Investigative Committee	Adopted 535 for, 19 against, 55 abstained	Position: For	Majority line: For
2 Apr 2025	Strengthening the security of identity cards of Union citizens and of residence documents issued to Union citizens and their family members exercising their right of free movement	Passed 377 for, 279 against, 16 abstained	Position: For	Majority line: For
2 Apr 2025	Agreements on Financial Mechanisms for the period May 2021 - April 2028 (EEA: EU-Iceland-Liechtenstein-Norway; Norwegian: EU-Norway); Additional Protocols to EEC-Norway Agreement and to EEC-Iceland Agreement	Consent given 528 for, 121 against, 32 abstained	Position: For	Majority line: For
2 Apr 2025	Protocol on the Implementation of the Fisheries Partnership Agreement between the European Community and the Republic of Guinea-Bissau (2024-2029)	Consent given 518 for, 104 against, 61 abstained	Position: For	Majority line: For
2 Apr 2025	EU-Bosnia and Herzegovina Agreement: cooperation between Eurojust and the authorities of Bosnia and Herzegovina competent for judicial cooperation in criminal matters	Consent given 619 for, 9 against, 45 abstained	Position: For	Majority line: For
2 Apr 2025	Guidelines for the 2026 budget – Section III	Adopted 441 for, 173 against, 70 abstained	Position: For	Majority line: For
2 Apr 2025	Protocol on the Implementation of the Fisheries Partnership Agreement between the European Community and the Republic of Guinea-Bissau (2024-2029) (Resolution)	Adopted 605 for, 68 against, 10 abstained	Position: For	Majority line: For
2 Apr 2025	Implementation of the common foreign and security policy – annual report 2024	Adopted 378 for, 188 against, 105 abstained	Position: For	Majority line: For
2 Apr 2025	Implementation of the common security and defence policy – annual report 2024	Adopted 399 for, 198 against, 71 abstained	Position: For	Majority line: For
2 Apr 2025	Human rights and democracy in the world and the European Union’s policy on the matter – annual report 2024	Adopted 390 for, 116 against, 126 abstained	Position: For	Majority line: For
1 Apr 2025	Amending Directives (EU) 2022/2464 and (EU) 2024/1760 as regards the dates from which Member States are to apply certain corporate sustainability reporting and due diligence requirements	Urgent procedure agreed 427 for, 221 against, 14 abstained	Position: No vote recorded	Majority line: For
1 Apr 2025	Common data platform on chemicals, establishing a monitoring and outlook framework for chemicals	Passed 481 for, 170 against, 22 abstained	Position: For	Majority line: For
1 Apr 2025	Re-attribution of scientific and technical tasks to the European Chemicals Agency	Passed 482 for, 110 against, 81 abstained	Position: For	Majority line: For
1 Apr 2025	Re-attribution of scientific and technical tasks and improving cooperation among Union agencies in the area of chemicals	Passed 486 for, 171 against, 18 abstained	Position: For	Majority line: For
1 Apr 2025	Macro-financial assistance to Jordan	Passed 571 for, 59 against, 46 abstained	Position: For	Majority line: For
1 Apr 2025	Macro-financial assistance to Egypt	Passed 452 for, 182 against, 40 abstained	Position: For	Majority line: For
1 Apr 2025	Customs duties on imports of certain products originating in the USA	Passed 593 for, 7 against, 35 abstained	Position: For	Majority line: For
13 Mar 2025	Democracy and human rights in Thailand, notably the lese-majesty law and the deportation of Uyghur refugees	Adopted 482 for, 57 against, 68 abstained	Position: For	Majority line: For
13 Mar 2025	Severe political, humanitarian and human rights crisis in Sudan, in particular the sexual violence and child rape	Adopted 575 for, 7 against, 35 abstained	Position: For	Majority line: For
13 Mar 2025	Unlawful detention and sham trials of Armenian hostages, including high-ranking political representatives from Nagorno-Karabakh, by Azerbaijan	Adopted 523 for, 3 against, 84 abstained	Position: For	Majority line: For
12 Mar 2025	EU-Norway Agreement: modification of concessions on all the tariff-rate quotas included in EU Schedule CLXXV as a consequence of the United Kingdom's withdrawal from the European Union	Consent given 525 for, 5 against, 34 abstained	Position: For	Majority line: For
12 Mar 2025	Agreement between Canada and the European Union on the transfer and processing of Passenger Name Record (PNR) data	Consent given 521 for, 90 against, 45 abstained	Position: For	Majority line: For
12 Mar 2025	European Semester for economic policy coordination 2025	Adopted 469 for, 162 against, 54 abstained	Position: For	Majority line: For
12 Mar 2025	European Semester for economic policy coordination: employment and social priorities for 2025	Adopted 351 for, 260 against, 70 abstained	Position: For	Majority line: For
12 Mar 2025	Continuing the unwavering EU support for Ukraine, after three years of Russia’s war of aggression	Adopted 442 for, 98 against, 126 abstained	Position: For	Majority line: For
12 Mar 2025	White paper on the future of European defence	Adopted 419 for, 204 against, 46 abstained	Position: For	Majority line: For
12 Mar 2025	The need for EU support towards a just transition and reconstruction in Syria	Adopted 462 for, 76 against, 106 abstained	Position: For	Majority line: For
11 Mar 2025	Establishing the Reform and Growth Facility for the Republic of Moldova	Passed 499 for, 117 against, 44 abstained	Position: For	Majority line: For
11 Mar 2025	Verification of credentials	Adopted 643 for, 10 against, 15 abstained	Position: For	Majority line: For
11 Mar 2025	European Social Fund Plus post-2027	Adopted 432 for, 155 against, 82 abstained	Position: For	Majority line: For
11 Mar 2025	Assessment of the implementation of Horizon Europe in view of its interim evaluation and recommendations for the 10th Research Framework Programme	Adopted 472 for, 75 against, 92 abstained	Position: For	Majority line: For
13 Feb 2025	Further deterioration of the political situation in Georgia	Adopted 400 for, 63 against, 81 abstained	Position: No vote recorded	Majority line: For
13 Feb 2025	Escalation of violence in the eastern Democratic Republic of the Congo	Adopted 443 for, 4 against, 48 abstained	Position: No vote recorded	Majority line: For
12 Feb 2025	VAT: rules for the digital age	Passed 589 for, 42 against, 10 abstained	Position: No vote recorded	Majority line: For
12 Feb 2025	Administrative cooperation in the field of taxation	Passed 608 for, 33 against, 8 abstained	Position: No vote recorded	Majority line: For
12 Feb 2025	Genetically modified maize DP910521	Objection passed 477 for, 152 against, 20 abstained	Position: No vote recorded	Majority line: Against
12 Feb 2025	Genetically modified maize MON 95275	Objection passed 467 for, 156 against, 18 abstained	Position: No vote recorded	Majority line: Against
11 Feb 2025	Renewal of the Agreement on cooperation in science and technology between the European Community and Ukraine	Consent given 591 for, 9 against, 9 abstained	Position: No vote recorded	Majority line: For
11 Feb 2025	Conclusion, on behalf of the Union, of the Protocol (2024-2029) implementing the Fisheries Partnership Agreement between the European Community and the Republic of Cabo Verde	Consent given 507 for, 76 against, 16 abstained	Position: No vote recorded	Majority line: For
11 Feb 2025	Conclusion of an agreement between the European Union and the government of the People's Republic of Bangladesh on certain aspects of air services	Consent given 562 for, 17 against, 3 abstained	Position: No vote recorded	Majority line: For
11 Feb 2025	European Central Bank – annual report 2024	Adopted 378 for, 233 against, 26 abstained	Position: No vote recorded	Majority line: For
23 Jan 2025	Systematic repression of human rights in Iran, notably the cases of Pakhshan Azizi and Wrisha Moradi, and the taking of EU citizens as hostages	Adopted 556 for, 6 against, 42 abstained	Position: No vote recorded	Majority line: For
23 Jan 2025	Case of Boualem Sansal in Algeria	Adopted 533 for, 24 against, 48 abstained	Position: No vote recorded	Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 11 of 67 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Roll calls held at each sitting while in office and how many of them the member voted in.
Sitting	Roll calls	Voted in
17 Dec 2024	6	0
18 Dec 2024	7	0
19 Dec 2024	5	0
21 Jan 2025	1	0
22 Jan 2025	1	0
23 Jan 2025	4	0
11 Feb 2025	4	0
12 Feb 2025	4	0
13 Feb 2025	2	0
11 Mar 2025	4	4
12 Mar 2025	7	7
13 Mar 2025	3	3
1 Apr 2025	7	6
2 Apr 2025	9	9
3 Apr 2025	5	4
6 May 2025	4	4
7 May 2025	20	19
8 May 2025	12	12
22 May 2025	6	6
17 Jun 2025	8	8
18 Jun 2025	7	7
19 Jun 2025	6	6
8 Jul 2025	8	8
9 Jul 2025	14	14
10 Jul 2025	7	6
9 Sept 2025	6	6
10 Sept 2025	15	15
11 Sept 2025	8	8
7 Oct 2025	4	4
8 Oct 2025	10	10
9 Oct 2025	10	10
21 Oct 2025	8	7
22 Oct 2025	6	6
23 Oct 2025	5	4
13 Nov 2025	16	16
25 Nov 2025	13	13
26 Nov 2025	10	10
27 Nov 2025	11	10
16 Dec 2025	11	11
17 Dec 2025	11	11
18 Dec 2025	6	0
20 Jan 2026	6	6
21 Jan 2026	8	8
22 Jan 2026	8	8
10 Feb 2026	8	7
11 Feb 2026	10	10
12 Feb 2026	8	8
24 Feb 2026	1	1
10 Mar 2026	9	9
11 Mar 2026	12	12
12 Mar 2026	6	6
26 Mar 2026	13	13
28 Apr 2026	14	14
29 Apr 2026	17	17
30 Apr 2026	11	11
19 May 2026	3	3
20 May 2026	12	12
21 May 2026	10	10
16 Jun 2026	10	10
17 Jun 2026	16	16
18 Jun 2026	7	7
7 Jul 2026	15	15
8 Jul 2026	15	15
9 Jul 2026	4	4
15 Sept 2026	12	11
16 Sept 2026	16	6
17 Sept 2026	10	0

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
Select	Member	Group	Country	Agreement	Baseline
Select Willemien KONING	Willemien KONING	EPP	Netherlands	87 % of 1 811 shared	89 %
Select Aura SALLA	Aura SALLA	EPP	Finland	87 % of 4 053 shared	89 %
Select Axel VOSS	Axel VOSS	EPP	Germany	86 % of 3 754 shared	89 %
Select Isabel WISELER-LIMA	Isabel WISELER-LIMA	EPP	Luxembourg	86 % of 4 796 shared	89 %
Select Liesbet SOMMEN	Liesbet SOMMEN	EPP	Belgium	86 % of 4 836 shared	89 %
Select Marie-Sophie CHRIST	Marie-Sophie CHRIST	EPP	Germany	86 % of 1 392 shared	89 %
Select Manuela RIPA	Manuela RIPA	EPP	Germany	86 % of 4 456 shared	89 %
Select Sandra KALNIETE	Sandra KALNIETE	EPP	Latvia	85 % of 4 619 shared	89 %
Select Martine KEMP	Martine KEMP	EPP	Luxembourg	85 % of 4 347 shared	89 %
Select Verena MERTENS	Verena MERTENS	EPP	Germany	85 % of 4 277 shared	89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
Select	Member	Group	Country	Agreement	Baseline
Select Ľudovít ÓDOR	Ľudovít ÓDOR	Renew	Slovakia	89 % of 4 580 shared	82 %
Select Yvan VEROUGSTRAETE	Yvan VEROUGSTRAETE	Renew	Belgium	89 % of 3 540 shared	82 %
Select Veronika CIFROVÁ OSTRIHOŇOVÁ	Veronika CIFROVÁ OSTRIHOŇOVÁ	Renew	Slovakia	88 % of 3 700 shared	82 %
Select Martin HOJSÍK	Martin HOJSÍK	Renew	Slovakia	88 % of 4 419 shared	82 %
Select Lucia YAR	Lucia YAR	Renew	Slovakia	88 % of 4 880 shared	82 %
Select Katarina BARLEY	Katarina BARLEY	S&D	Germany	88 % of 3 672 shared	75 %
Select Iratxe GARCÍA PÉREZ	Iratxe GARCÍA PÉREZ	S&D	Spain	88 % of 4 627 shared	75 %
Select Brigitte VAN DEN BERG	Brigitte VAN DEN BERG	Renew	Netherlands	88 % of 4 104 shared	82 %
Select Michal WIEZIK	Michal WIEZIK	Renew	Slovakia	88 % of 4 465 shared	82 %
Select Dainius ŽALIMAS	Dainius ŽALIMAS	Renew	Lithuania	88 % of 4 547 shared	82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
Body	Role	From	To
Committee on Economic and Monetary AffairsECON Committee	Member	16 Dec 2024	now
Committee on the Environment, Climate and Food SafetyENVI Committee	Substitute	20 Jan 2025	now
Committee on Women’s Rights and Gender EqualityFEMM Committee	Member	16 Dec 2024	now
Committee on Public HealthSANT Committee	Substitute	23 Jan 2025	now
Delegation for relations with the People's Republic of ChinaD-CN Delegation	Substitute	2 Dec 2024	now
Delegation for relations with the Pan-African ParliamentDPAP Delegation	Member	16 Dec 2024	now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working group	Member	27 Jan 2025	now
Intergroup on Children’s RightsIG10-06 Intergroup / working group	Member	19 Feb 2025	now
Intergroup on DisabilityIG10-10 Intergroup / working group	Member	11 Mar 2025	now
Intergroup on Fighting against PovertyIG10-12 Intergroup / working group	Member	17 Jun 2025	now

Show all 18 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
Dossier	Role	Committee	Date
Neurological health strategy	Shadow rapporteur	SANT	20 Jul 2026
Union Civil Protection Mechanism and Union support for health emergency preparedness and response, and repealing Decision No 1313/2013/EU (Union Civil Protection Mechanism)	Shadow rapporteur	SANT	23 Apr 2026
Safety, resilience and sustainability of space activities in the Union	Shadow rapporteur for an opinion	ENVI	3 Nov 2025
Collection of statistical information by the European Central Bank	Shadow rapporteur	ECON	24 Sept 2025
Developing a new EU anti-poverty strategy	Shadow rapporteur for an opinion	FEMM	25 Jun 2025
Gender inequalities in health, specifically as regards gender-specific conditions	Shadow rapporteur for an opinion	SANT	25 Jun 2025

Show all 6 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

23 contributions recorded, 16 written statements; 12 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
Date	Debate	Kind	Verbatim
15 Sept 2026	Devastating heatwaves, wildfires and droughts in Europe: lessons from summer 2026 (debate)	Statement	Read
8 Jul 2026	EU’s response and preparedness to protect people against recurring heatwaves and upcoming wildfires (debate)	Statement	Read
15 Jun 2026	Simplification of the implementation of harmonised rules on artificial intelligence (Digital Omnibus on AI) (debate)	Statement	Read
20 May 2026	Advancing towards a care society: addressing the gender care gap (debate)	Statement	Read
10 Mar 2026	Housing crisis in the European Union with the aim of proposing solutions for decent, sustainable and affordable housing (debate)	Statement	Read
11 Feb 2026	International Day of Education, fighting inequalities in access to education (debate)	Speech · 2 min	Read
9 Feb 2026	European Central Bank – annual report 2025 (debate)	Statement	Read
19 Jan 2026	Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest (debate)	Statement	Read
17 Dec 2025	2030 Consumer Agenda (debate)	Statement	Read
27 Nov 2025	Fur farming and the placing of farmed fur products on the market (debate)	Speech · 2 min	Read

Show all 23 recent contributions

Questions and motions, 75

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
Date	Title	Kind	Answer
8 Sept 2026	Chatbots directing women with unwanted pregnancies to anti-abortion websites E-10-2026-003539	Written questionwith 67 co-authors	Not yet answered
2 Sept 2026	MOTION FOR A RESOLUTION on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize MON 87460 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0381	Motion for a resolutionwith 3 co-authors	—
2 Sept 2026	MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean GMB151 x DAS-44406-6 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0380	Motion for a resolutionwith 3 co-authors	—
2 Sept 2026	MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 94313 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0379	Motion for a resolutionwith 3 co-authors	—
16 Jul 2026	Ensuring the continued operation of the Blue Flag Programme under Directive (EU) 2024/825 E-10-2026-003031	Written questionwith 29 co-authors	18 Sept 2026
8 Jul 2026	Impact of the recent US Supreme Court ruling on the EU–US Data Privacy Framework and European data sovereignty E-10-2026-002823	Written questionwith 21 co-authors	Not yet answered
1 Jul 2026	MOTION FOR A RESOLUTION on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 87705 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0334	Motion for a resolutionwith 3 co-authors	—
1 Jul 2026	MOTION FOR A RESOLUTION on the draft Commission Implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP202216 x NK603 x DAS-40278-9 and its sub-combinations DP202216 x NK603, DP202216 x DAS-40278-9, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0336	Motion for a resolutionwith 3 co-authors	—
1 Jul 2026	MOTION FOR A RESOLUTION on the Commission Implementing Decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize NK603 × T25 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0335	Motion for a resolutionwith 3 co-authors	—
29 Jun 2026	Scrutiny of hunting trophy imports into the EU E-10-2026-002689	Written questionwith 8 co-authors	25 Aug 2026

Show all 75 questions and motions

Amendments tabled in committee, 126

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
Date	Text amended	Committee	Amendments
11 Sept 2026	Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014	SANT	43
11 Sept 2026	Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154	SANT	21
31 Jul 2026	on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) No 1095/2010, No 648/2012, No 600/2014, No 909/2014, 2015/2365, 2019/1156, 2021/23, 2022/858, 2023/1114, No 1060/2009, 2016/1011, 2017/2402, 2023/2631 and 2024/3005 as regards the further development of capital market integration and supervision within the Union ECON-AM-791136	ECON	4
31 Jul 2026	on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) No 1095/2010, No 648/2012, No 600/2014, No 909/2014, 2015/2365, 2019/1156, 2021/23, 2022/858, 2023/1114, No 1060/2009, 2016/1011, 2017/2402, 2023/2631 and 2024/3005 as regards the further development of capital market integration and supervision within the Union ECON-AM-791135	ECON	39
31 Jul 2026	on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) No 1095/2010, No 648/2012, No 600/2014, No 909/2014, 2015/2365, 2019/1156, 2021/23, 2022/858, 2023/1114, No 1060/2009, 2016/1011, 2017/2402, 2023/2631 and 2024/3005 as regards the further development of capital market integration and supervision within the Union ECON-AM-791103	ECON	3
31 Jul 2026	on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) No 1095/2010, No 648/2012, No 600/2014, No 909/2014, 2015/2365, 2019/1156, 2021/23, 2022/858, 2023/1114, No 1060/2009, 2016/1011, 2017/2402, 2023/2631 and 2024/3005 as regards the further development of capital market integration and supervision within the Union ECON-AM-791134	ECON	9
28 Jul 2026	Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887	SANT	3
28 Jul 2026	Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891	SANT	1
27 Jul 2026	on the proposal for a directive of the European Parliament and of the Council amending Directives 2009/65/EC, 2011/61/EU and 2014/65/EU as regards the further development of capital market integration and supervision within the Union ECON-AM-791126	ECON	1
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953	CJ53	1

Show all 126 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

Group European People’s Party EPP · Centre-right · Christian democracy, conservatism

National delegation

Delegation Finland National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/members/40599?page=11&scope=final&vscope=final
Official source: Member’s profile, European Parliament
Data source: EP Open Data: member record
Licensed CC BY 4.0.
Data version: data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved: 25 September 2026

Cite as

EU Parl Watch Research (2026). “Sirpa PIETIKÄINEN”. Member record. memberId 40599. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/40599?page=11&scope=final&vscope=final (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/40599. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/40599?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.

BibTeX

@misc{epw-member-40599,
  author = {{EU Parl Watch Research}},
  title = {{Sirpa PIETIKÄINEN}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/40599?page=11&scope=final&vscope=final}},
  url = {https://news.eu-parl.st-solutions.dev/members/40599?page=11&scope=final&vscope=final},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 40599. Official source: https://www.europarl.europa.eu/meps/en/40599. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}